Black Rock Inc. Molecular Partners Ag Transaction History

Black Rock Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 09, 2021	SELL	$18.34 - $21.0 $3.03 Million - $3.47 Million	-165,038 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$19.25 - $21.01 $3.18 Million - $3.47 Million	165,038 New	165,038 $3.38 Million

849K

Ticker MOLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,514,000
Market Cap $162M
Description
Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.